Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors

This study is currently recruiting participants.

Verified October 2012 by Mount Sinai School of Medicine

Study NCT01496534 Information provided by Mount Sinai School of Medicine

First Received on December 12, 2011. Last Updated on October 15, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Solid Tumors
Bladder Cancer

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Cisplatin
Carboplatin

Additional drug interventions recognized in this trial

Gemcitabine

More general drug interventions related to this trial

Sponsors listed in this trial

Matthew Galsky
Novartis